- Quarter end
- 30 Sep 2025
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 29 Oct 2025
- Managers listing it
- 13
- at least, of 95 tracked, among listed positions
- Comparable managers
- 95
- filed both Q2 2025 and Q3 2025; 11 listed it in both
- Shares listed
- 35,958,264
- combined, among listed positions
- Reported value
- $4.7bn
- combined, at the quarter end
Among the 95 comparable managers: 6 buyers (opened or added shares) and 8 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing EMR in Q3 2025
13 of 13 holders
Largest increases and reductions, by shares
Increases
- ExodusPoint Capital Management LPexisting position · 146,434 shares now+117,042
- Bridgewater Associates LPexisting position · 43,426 shares now+34,554
- Capital Research Global Investorsexisting position · 700,037 shares now+6,400
- Neuberger Berman Group LLCexisting position · 819,755 shares now+442
Reductions
- Invesco Ltdexisting position · 8,352,785 shares now-983,038
- Wellington Management Group LLPexisting position · 13,935,263 shares now-942,566
- Fidelity (FMR LLC)existing position · 4,336,394 shares now-895,066
- AllianceBernstein LPexisting position · 2,171,324 shares now-208,412
- T. Rowe Price Associates Incexisting position · 1,319,073 shares now-207,901
New positions and exits
New (0)
No new position among listed positions.
Exited (1)
- Capital World Investorswas $204m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 14 | $2.6bn | n.a. | n.a. |
| Q3 2013 | 13 | $3.5bn | n.a. | n.a. |
| Q4 2013 | 16 | $3.8bn | n.a. | n.a. |
| Q1 2014 | 18 | $3.2bn | n.a. | n.a. |
| Q2 2014 | 22 | $3.1bn | n.a. | n.a. |
| Q3 2014 | 18 | $2.7bn | n.a. | n.a. |
| Q4 2014 | 17 | $2.2bn | n.a. | n.a. |
| Q1 2015 | 17 | $2.0bn | n.a. | n.a. |
| Q2 2015 | 20 | $2.5bn | n.a. | n.a. |
| Q3 2015 | 18 | $2.3bn | n.a. | n.a. |
| Q4 2015 | 16 | $2.3bn | n.a. | n.a. |
| Q1 2016 | 16 | $2.7bn | n.a. | n.a. |
| Q2 2016 | 13 | $2.7bn | n.a. | n.a. |
| Q3 2016 | 17 | $3.2bn | n.a. | n.a. |
| Q4 2016 | 16 | $3.0bn | n.a. | n.a. |
| Q1 2017 | 17 | $2.4bn | n.a. | n.a. |
| Q2 2017 | 14 | $2.3bn | n.a. | n.a. |
| Q3 2017 | 14 | $2.4bn | n.a. | n.a. |
| Q4 2017 | 18 | $2.9bn | n.a. | n.a. |
| Q1 2018 | 17 | $2.6bn | n.a. | n.a. |
| Q2 2018 | 17 | $2.6bn | n.a. | n.a. |
| Q3 2018 | 16 | $2.9bn | n.a. | n.a. |
| Q4 2018 | 20 | $2.9bn | n.a. | n.a. |
| Q1 2019 | 20 | $2.6bn | n.a. | n.a. |
| Q2 2019 | 15 | $2.5bn | n.a. | n.a. |
| Q3 2019 | 16 | $2.2bn | n.a. | n.a. |
| Q4 2019 | 23 | $3.4bn | n.a. | n.a. |
| Q1 2020 | 17 | $2.0bn | n.a. | n.a. |
| Q2 2020 | 16 | $2.4bn | n.a. | n.a. |
| Q3 2020 | 18 | $2.4bn | n.a. | n.a. |
| Q4 2020 | 18 | $3.5bn | n.a. | n.a. |
| Q1 2021 | 16 | $3.8bn | n.a. | n.a. |
| Q2 2021 | 20 | $4.6bn | n.a. | n.a. |
| Q3 2021 | 17 | $4.4bn | n.a. | n.a. |
| Q4 2021 | 20 | $3.7bn | n.a. | n.a. |
| Q1 2022 | 21 | $3.3bn | n.a. | n.a. |
| Q2 2022 | 24 | $2.8bn | n.a. | n.a. |
| Q3 2022 | 28 | $3.1bn | n.a. | n.a. |
| Q4 2022 | 21 | $4.3bn | n.a. | n.a. |
| Q1 2023 | 26 | $4.3bn | n.a. | n.a. |
| Q2 2023 | 24 | $4.1bn | n.a. | n.a. |
| Q3 2023 | 20 | $3.8bn | n.a. | n.a. |
| Q4 2023 | 18 | $3.5bn | 10 | 8 |
| Q1 2024 | 19 | $4.1bn | 11 | 8 |
| Q2 2024 | 24 | $4.3bn | 15 | 8 |
| Q3 2024 | 14 | $3.8bn | 7 | 6 |
| Q4 2024 | 10 | $4.1bn | 4 | 9 |
| Q1 2025 | 11 | $4.0bn | 9 | 2 |
| Q2 2025 | 16 | $5.4bn | 12 | 4 |
| Q3 2025 | 13 | $4.7bn | 6 | 8 |
| Q4 2025 | 14 | $4.5bn | 16 | 16 |
| Q1 2026 | 16 | $4.6bn | 16 | 15 |
| Q2 2026 | 14 | $4.7bn | 14 | 19 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
EMR and GE →EMR and LRCX →EMR and GEV →Choose a stock to compare with EMR →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own EMR, latest filings →Back to the 13F Explorer →